
|Articles|October 1, 2004
Minocycline shows promise as safe neuroprotective agent
Tel Hashomer, Israel-Results of preclinical studies suggest that minocycline has potential utility as a neuroprotective agent in the management of optic nerve diseases, said Hani Levkovitch-Verbin, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Philip J. Ferrone, MD, highlights safety and efficacy findings of gildeuretinol in Stargardt disease
2
News from Orlando: AAO 2025 highlights research across all areas of eyecare
3
AAO 2025: Glaucoma laser surgery with Joel S. Schuman, MD, FACS
4
AAO 2025: Which lens to consider in patients with pseudoexfoliation
5